Udenyca Pegfilgrastim-cbqv Injection
Accord BioPharma is recalling Udenyca injection due to improper storage temperature conditions.
Contact your healthcare provider or pharmacist to determine if your medication is affected. Do not use the product if it was stored outside of the required refrigerated environment.
Why it was recalled
Accord BioPharma is recalling specific units of Udenyca (pegfilgrastim-cbqv) injection due to temperature abuse. The affected products were stored in a controlled room temperature environment instead of the required refrigerated conditions.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63
- Recall #
- D-0353-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from McKesson
Editorial summary by Recall Canary · last updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification